Now We Know Who We Are and What We Do…, Where Do We Go From Here?

Managing Strategic Alliances : What Do We Know Now , and Where Do We Go From Here ?

Executive Overview Alliances present a paradox for firms. On the one hand, firms engage in a large number of alliances to secure and extend their competitive advantage and growth; on the other hand, their alliances exhibit surprisingly low success rates. In this paper, we discuss how firms can address these failures by identifying some of the primary drivers of alliance success. First, we discu...

Superior Capsule Reconstruction: What Do We Know?

The management of irreparable rotator cuff tears remains challenging. Since its introduction by Mihata in 2012, superiorcapsule reconstruction (SCR) has grown in popularity at an astonishingly rapid rate. The aim of this article is to providea comprehensive review of the available literature, in order to highlight what has so far been published on SCR,covering all aspects including biomechanica...

Do We Know What We Do not Know? A Response to Celine Bonnet

Molecular approaches to diagnosis of invasive aspergillosis what we know and what we do not know.

Invasive aspergillosis (IA) are a major complication in immunocompromized patients where can be serious and rapidly fatal. Early diagnosis and early appropriate antifungal treatment is important in reducing mortality and morbidity. But despite many efforts to develop detection methods, the diagnosis of IA still remains challenging and current conventional methods are limited for adequate diagno...

Breastfeeding: What Do We Know, and Where Do We Go From Here?

Breastfeeding reduces all-cause and infection-related child mortality, sudden infant death syndrome–related mortality, and maternal breast cancer and cardiovascular risk; the effect of breast milk is dose-dependent, with exclusivity and longer duration increasing benefits. 3 –5 With this background, Dr Lisa-Christine Girard and colleagues have conducted a unique and thoughtful study to examine ...